Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Orally Available Inhibitors of Factor Xa

18.11.2002


Morphochem AG, a leader in novel chemistries for small molecule drug discovery, has announced that one of its leading programmes, inhibitors of blood coagulation Factor Xa, led to the identification of novel, orally available anti-thrombotics in preclinical studies. Details of these preclinical studies will be presented at a meeting of investment analysts and pharmaceutical executives to be held in Basel on 21st November.
Commenting on the Factor Xa programme, Dr Lutz Weber, CEO of Morphochem said,

"Our strategy is to progress series of compounds into development as we apply the drug discovery engine that we built. The Factor Xa compounds are validating this approach. They have emerged from our protease target platform, are generated by applying our novel MCR chemistries and proprietary MolMind© technologies, and have moved from assay implementation to advanced preclinical compounds in less than three years, a significant achievement."


A novel series of low molecular weight compounds which demonstrate direct inhibition of Factor Xa have been synthesized using Morphochem?s integrated evolutionary chemistry. Data from preclinical studies demonstrate that the lead compounds are highly effective and specific. Good oral availability and reduced side effects were reported. These parameters could lead to significant pharmaco-economic benefits through decreased patient hospitalisation and decreased monitoring of blood coagulation parameters respectively.

Dr Peter Seufer-Wasserthal, Vice President Business Development of Morphochem, commented,

"An orally available inhibitor for Factor Xa is actively sought in the pharmaceutical industry as a cost effective and safe anti-thrombotic. We are now in active discussions with several pharmaceutical companies to explore the optimum strategy for clinical development of our compounds."

The anti-thrombotics market covers a multitude of venous or arterial thrombotic disorders, such as deep vein thrombosis (DVT), unstable angina, myocardial infarction, and stroke. Currently this market is worth over $ 8 billion, with approximately a fifth related to DVT prophylaxis, and therapy in hip and knee surgery. Orally available direct inhibitors of Factor Xa are believed to have a market potential of $ 1 billion in various indication areas.

Charles Consultants | alfa
Further information:
http://www.morphochem.de

More articles from Health and Medicine:

nachricht Millions through license revenues
27.04.2017 | Rheinische Friedrich-Wilhelms-Universität Bonn

nachricht New High-Performance Center Translational Medical Engineering
26.04.2017 | Fraunhofer ITEM

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Making lightweight construction suitable for series production

More and more automobile companies are focusing on body parts made of carbon fiber reinforced plastics (CFRP). However, manufacturing and repair costs must be further reduced in order to make CFRP more economical in use. Together with the Volkswagen AG and five other partners in the project HolQueSt 3D, the Laser Zentrum Hannover e.V. (LZH) has developed laser processes for the automatic trimming, drilling and repair of three-dimensional components.

Automated manufacturing processes are the basis for ultimately establishing the series production of CFRP components. In the project HolQueSt 3D, the LZH has...

Im Focus: Wonder material? Novel nanotube structure strengthens thin films for flexible electronics

Reflecting the structure of composites found in nature and the ancient world, researchers at the University of Illinois at Urbana-Champaign have synthesized thin carbon nanotube (CNT) textiles that exhibit both high electrical conductivity and a level of toughness that is about fifty times higher than copper films, currently used in electronics.

"The structural robustness of thin metal films has significant importance for the reliable operation of smart skin and flexible electronics including...

Im Focus: Deep inside Galaxy M87

The nearby, giant radio galaxy M87 hosts a supermassive black hole (BH) and is well-known for its bright jet dominating the spectrum over ten orders of magnitude in frequency. Due to its proximity, jet prominence, and the large black hole mass, M87 is the best laboratory for investigating the formation, acceleration, and collimation of relativistic jets. A research team led by Silke Britzen from the Max Planck Institute for Radio Astronomy in Bonn, Germany, has found strong indication for turbulent processes connecting the accretion disk and the jet of that galaxy providing insights into the longstanding problem of the origin of astrophysical jets.

Supermassive black holes form some of the most enigmatic phenomena in astrophysics. Their enormous energy output is supposed to be generated by the...

Im Focus: A Quantum Low Pass for Photons

Physicists in Garching observe novel quantum effect that limits the number of emitted photons.

The probability to find a certain number of photons inside a laser pulse usually corresponds to a classical distribution of independent events, the so-called...

Im Focus: Microprocessors based on a layer of just three atoms

Microprocessors based on atomically thin materials hold the promise of the evolution of traditional processors as well as new applications in the field of flexible electronics. Now, a TU Wien research team led by Thomas Müller has made a breakthrough in this field as part of an ongoing research project.

Two-dimensional materials, or 2D materials for short, are extremely versatile, although – or often more precisely because – they are made up of just one or a...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Fighting drug resistant tuberculosis – InfectoGnostics meets MYCO-NET² partners in Peru

28.04.2017 | Event News

Expert meeting “Health Business Connect” will connect international medical technology companies

20.04.2017 | Event News

Wenn der Computer das Gehirn austrickst

18.04.2017 | Event News

 
Latest News

Wireless power can drive tiny electronic devices in the GI tract

28.04.2017 | Medical Engineering

Ice cave in Transylvania yields window into region's past

28.04.2017 | Earth Sciences

Nose2Brain – Better Therapy for Multiple Sclerosis

28.04.2017 | Life Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>